ACTIVE SESSION TAPE Equities Quant: HOLD

Why Is FRNM (FRNM) Stock Down Today?

Updated Nov 22, 2026 6:57 AM ET ยท Prev Close $9.93

Pro Workspace
Last Session Price
$9.36 -5.69%
-$0.57 vs $9.93 prior close
Intraday Range
$9.28 โ€“ $9.84
Open $9.82
Relative Volume
0.75x Avg
598,815 sh
52-Week Range
$9.28 โ€“ $17.50
Benchmark Alpha
-2.05% vs SPY
-0.02% vs QQQ
20-Session Trend -26.4%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

FRNM Pulling Back 5.69% on 0.75x Relative Volume

Frnm (Frnm) is pulling back 5.69% (-$0.57) to $9.36 on 0.75x average session volume. Relative to benchmarks, FRNM is lagging the S&P 500 by -2.05%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.

NEWS 70% Weight
Freenome Frnm Q3 2026 Earnings Call Transcript

Freenome's first public quarter brings a 180 million FDA-driven revenue jump.

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($9.36) trades relative to 20-day SMA ($11.12) and 50-day SMA ($13.40).

Volume Confirmation
LOW VOLUME (0.75x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

FRNM lagging the S&P 500 by -2.05%
FRNM Session
-5.69%
$9.36
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Alpha vs SPY: -2.05% Alpha vs QQQ: -0.02%

Options Flow & Execution Desk

Recent FRNM Catalyst Headlines

Verified Wire
Tempus AI And 2 More AI Healthcare Stocks

Inflation worries are back on the front page, with US wholesale prices rising 6.5 year on year in October and feeding fresh debate about how long higher rates could stick around. Expensive capital and rising costs can be

Yahoo Finance ยท Nov 15, 2026
Freenome Q3 Earnings Call Highlights

Freenome Nasdaq Frnm reported third-quarter revenue of 183.5 million, driven largely by revenue recognition following the U.S. Food and Drug Administration s approval of its blood-based colorectal cancer screening test.

Yahoo Finance ยท Nov 11, 2026

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$8.85
Short-term support band
Upper Bound
$9.87
Short-term resistance band
Key Inflection Level
$9.28 (session support)

Monitor volume expansion above 1.5x RVOL around $9.28 (session support) for directional breakout confirmation.

Technical Regime (FRNM)

BEARISH MA TREND
RSI (14)
31.3
Bearish
20-Day SMA
$11.12
Below 20d
50-Day SMA
$13.40
Below 50d
MACD Signal
Bearish
MACD -1.03
ADX (14)
32.3
Strong trend
10d Momentum
-0.82
Soft 10-day momentum

About FRNM

Sector
Equities

Get Instant FRNM Catalyst Alerts

Receive an email alert when FRNM triggers an unusual volume breakout, options sweep, or rating shift.

FRNM Session & Catalyst FAQ

Why is FRNM stock down today?

Frnm (Frnm) is pulling back 5.69% (-$0.57) to $9.36 on 0.75x average session volume. Relative to benchmarks, FRNM is lagging the S&P 500 by -2.05%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.

Is FRNM stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.75x relative volume (low participation). Our multi-factor model currently rates FRNM as HOLD. Review full valuation, quality, and timing signals on the FRNM Buy or Sell Decision Brief โ†’

What is FRNM's intrinsic value and expected trading range?

At $9.36, FRNM's modeled 1-to-3 session range is $8.85 โ€“ $9.87, with a key inflection level at $9.28 (session support). Compare current price against multi-year cash flow projections in the FRNM Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for FRNM?

RSI at 31.3 reflects soft below-midline momentum. FRNM trades at $9.36 relative to its 20-day SMA ($11.12) and 50-day SMA ($13.40), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs